Pages

Monday, March 23, 2020

In a rare deal for Indian pharma, Bayer inks pact with Curadev to develop drugs

In a rare deal for Indian pharma, Bayer inks pact with Curadev to develop drugs As part of the agreement, Bayer will gain exclusive access to novel molecules from Curadev to develop drugs targeting lung, cardiovascular and inflammatory diseases

from Moneycontrol Business News https://ift.tt/2WBTWmr

No comments:

Post a Comment